Introduction
Tuberculosis (TBC) is a pathological process characterized by a broad spectrum of immunological responses which correlate with the clinical course of the disease.1 -.3 In TBC, immune responsiveness depends on three basic mechanisms" (1) acquired cellular resistance; (2) delayed type 1--3 hypersensitivity (DTH); and (3) anergy.
.Acquired cellular resistance is a protective mechanism in which specific T-cells are activated by macrophages, the so-called antigen presenting cells. 4 With special reference to mycobacterial antigens, mainly proteins, e.g. heat 1 and enhanced mitogen-induced lymphocyte proliferation in the elderly. 2 In AIDS subjects treated with ALC an improvement of immunocompetence was found and this correlates with the reduced levels of carnitine detected in these patients. -4 On this basis, 20 subjects with active pulmonary TBC vere enrolled in a double blind, randomized, co.trolled parallel study. 35 Ten patients were treated orally with 2 g ALC/day (Nicetile, SigmaTau, Pomezia, Italy) for 30 days. The control group received placebo only. Two main immune para-Immunity in tuberculosis and effects of acetyl-I,-carnitine meters were followed up at day 0 and day 30, namely the antibacterial activity and TNFo serum levels.
Antibacterial activity is a T-cell function dependent on CD4 + and CD8 + cell activity which represents a good index of the host resistance against pathogens, even including M. tuberculosis. 36 This activity was depressed in both groups of patients at time 0, but, while it increased in the ALC-treated individuals, it decreased in the subjects receiving placebo only. Several 45 48 Finally, even if these preliminary results seem to support the immunomodulating capacities of AI,C, long-term studies and monitoring of additional immune parameters are needed on a broader sample of the population affected by mycobacterial disease.
